| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/OLQ.0B013E318156A5D0 |
| P698 | PubMed publication ID | 17989585 |
| P50 | author | Leslie A. Meyn | Q111569408 |
| Marijane A Krohn | Q45399448 | ||
| Sharon Hillier | Q95149245 | ||
| P2093 | author name string | Thomas L Cherpes | |
| James L Busch | |||
| P433 | issue | 1 | |
| P921 | main subject | sexually transmitted infection | Q12198 |
| bacterial vaginosis | Q804521 | ||
| P304 | page(s) | 78-83 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Sexually Transmitted Diseases | Q15763556 |
| P1476 | title | A delicate balance: risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology | |
| P478 | volume | 35 |
| Q24617297 | A 'snip' in time: what is the best age to circumcise? |
| Q35793052 | A behavioural intervention to reduce persistence of bacterial vaginosis among women who report sex with women: results of a randomised trial |
| Q36482001 | A case control study of anovaginal distance and bacterial vaginosis |
| Q36453097 | A new era of the vaginal microbiome: advances using next-generation sequencing. |
| Q47217223 | A retrospective pilot study to determine whether the reproductive tract microbiota differs between women with a history of infertility and fertile women |
| Q51870514 | Advances in the design of probiotic products for the prevention of major diseases in dairy cattle. |
| Q43583268 | Altered vaginal microbiota are associated with perinatal mother-to-child transmission of HIV in African women from Burkina Faso. |
| Q93065304 | Association Analysis on Recurrence of Bacterial Vaginosis Revealed Microbes and Clinical Variables Important for Treatment Outcome |
| Q34168813 | Association between cigarette smoking and the vaginal microbiota: a pilot study |
| Q36294698 | Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity |
| Q37259390 | Bacterial vaginosis in female facility workers in north-western Tanzania: prevalence and risk factors |
| Q33790498 | Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis |
| Q51314887 | Bacterial vaginosis is conducive to the persistence of HPV infection. |
| Q26766051 | Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections |
| Q34711359 | Behavioural and medical predictors of bacterial vaginosis recurrence among female sex workers: longitudinal analysis from a randomized controlled trial |
| Q33817766 | CDC's Male Circumcision Recommendations Represent a Key Public Health Measure |
| Q33581360 | Cervicovaginal fluid and semen block the microbicidal activity of hydrogen peroxide produced by vaginal lactobacilli |
| Q97905080 | Changes in the vaginal microbiota across a gradient of urbanization |
| Q35043939 | Characterization of the vaginal microbiota among sexual risk behavior groups of women with bacterial vaginosis |
| Q59326987 | Characterization of vaginal microbiota in Thai women |
| Q48231434 | Cigarette smoking is associated with an altered vaginal tract metabolomic profile. |
| Q47224024 | Combined oral and topical antimicrobial therapy for male partners of women with bacterial vaginosis: Acceptability, tolerability and impact on the genital microbiota of couples - A pilot study |
| Q36156238 | Comparative genomic analyses of 17 clinical isolates of Gardnerella vaginalis provide evidence of multiple genetically isolated clades consistent with subspeciation into genovars. |
| Q37316927 | Comparison between the efficacy of metronidazole vaginal gel and Berberis vulgaris (Berberis vulgaris) combined with metronidazole gel alone in the treatment of bacterial vaginosis |
| Q36831182 | Comparison of the Effects of Myrtus Communis L, Berberis Vulgaris and Metronidazole Vaginal Gel alone for the Treatment of Bacterial Vaginosis. |
| Q33554048 | Comparison of the vaginal microbial communities in women with recurrent genital HSV receiving acyclovir intravaginal rings |
| Q34768443 | Comparison of the vaginal microbiota diversity of women with and without human papillomavirus infection: a cross-sectional study |
| Q34360391 | Consistent condom use increases the colonization of Lactobacillus crispatus in the vagina |
| Q92626556 | Conventional oral and secondary high dose vaginal metronidazole therapy for recurrent bacterial vaginosis: clinical outcomes, impacts of sex and menses |
| Q38171861 | Counseling parents who are considering newborn male circumcision |
| Q39248206 | Defence factors of vaginal lactobacilli |
| Q34259440 | Differences in vaginal microbiome in African American women versus women of European ancestry. |
| Q35793065 | Distribution of genital Lactobacillus strains shared by female sex partners |
| Q36769394 | Distribution of human papillomaviruses and bacterial vaginosis in HIV positive women with abnormal cytology in Mombasa, Kenya |
| Q44120205 | Does Bacterial Vaginosis Result From Fecal Transplantation? |
| Q61805202 | Does Male Circumcision Reduce Women's Risk of Sexually Transmitted Infections, Cervical Cancer, and Associated Conditions? |
| Q35690553 | Effect of pH on Cleavage of Glycogen by Vaginal Enzymes |
| Q35552779 | Effect of sexual activity on vaginal colonization with hydrogen peroxide-producing lactobacilli and Gardnerella vaginalis |
| Q34390550 | Effects of probiotics for the treatment of bacterial vaginosis in adult women: a meta-analysis of randomized clinical trials |
| Q38093258 | Efficacy of methods used for the diagnosis of bacterial vaginosis. |
| Q39208815 | Etiology of bacterial vaginosis and polymicrobial biofilm formation |
| Q28068857 | Evaluation of Health Disparity in Bacterial Vaginosis and the Implications for HIV-1 Acquisition in African American Women |
| Q36153787 | Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis |
| Q33669106 | Factors associated with event level anal sex and condom use during anal sex among adolescent women |
| Q35993598 | Glycogen Levels in Undiluted Genital Fluid and Their Relationship to Vaginal pH, Estrogen, and Progesterone |
| Q42276023 | Gynecological complaints and their associated factors among women in a family health-care clinic |
| Q34107809 | Heterosexual anal sexuality and anal sex behaviors: a review |
| Q34984200 | Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis |
| Q34564029 | Identification and characterisation of vaginal lactobacilli from South African women |
| Q58227593 | Identification and in vitro production of Lactobacillus antagonists from women with or without bacterial vaginosis |
| Q33714529 | Identification of rhesus macaque genital microbiota by 16S pyrosequencing shows similarities to human bacterial vaginosis: implications for use as an animal model for HIV vaginal infection |
| Q64108555 | Impact of Herpes Simplex Virus Type 2 and Human Immunodeficiency Virus Dual Infection on Female Genital Tract Mucosal Immunity and the Vaginal Microbiome |
| Q33965563 | In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide |
| Q41681149 | Incident bacterial vaginosis (BV) in women who have sex with women is associated with behaviors that suggest sexual transmission of BV. |
| Q37635159 | Incident herpes simplex virus type 2 infection increases the risk of subsequent episodes of bacterial vaginosis |
| Q61796337 | Interplay among Vaginal Microbiome, Immune Response and Sexually Transmitted Viral Infections |
| Q21129223 | Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health |
| Q36250396 | Longitudinal assessment of pigtailed macaque lower genital tract microbiota by pyrosequencing reveals dissimilarity to the genital microbiota of healthy humans |
| Q34428598 | Longitudinal qPCR study of the dynamics of L. crispatus, L. iners, A. vaginae, (sialidase positive) G. vaginalis, and P. bivia in the vagina |
| Q34091323 | Longitudinal study of the dynamics of vaginal microflora during two consecutive menstrual cycles |
| Q35607363 | Maternal vitamin D, folate, and polyunsaturated fatty acid status and bacterial vaginosis during pregnancy |
| Q35592893 | Normal flora and bacterial vaginosis in pregnancy: an overview |
| Q34302658 | Prevalence and correlates of bacterial vaginosis in different sub-populations of women in sub-Saharan Africa: a cross-sectional study |
| Q35793060 | Prevalence and risks for bacterial vaginosis in women who have sex with women. |
| Q59336262 | Prevalence of bacterial vaginosis and factors associated among women who have sex with women |
| Q58955934 | Prevalence of vaginal infections and associated lifestyles of students in the university of Cape Coast, Ghana |
| Q41929005 | Prevalent Herpes Simplex Virus-2 Increases the Risk of Incident Bacterial Vaginosis in Women from South Africa |
| Q31112477 | Prevalent and incident bacterial vaginosis are associated with sexual and contraceptive behaviours in young Australian women |
| Q33723224 | Prospective study of correlates of vaginal Lactobacillus colonisation among high-risk HIV-1 seronegative women |
| Q57492361 | Psychosocial Stress, Cortisol Levels, and Maintenance of Vaginal Health |
| Q34286514 | Quantification of bacterial species of the vaginal microbiome in different groups of women, using nucleic acid amplification tests |
| Q36501112 | Rapid fluctuation of the vaginal microbiota measured by Gram stain analysis |
| Q35658748 | Recalcitrance of bacterial vaginosis among herpes-simplex-virus-type-2-seropositive women |
| Q53269168 | Relationship between infectious agents for vulvovaginitis and skin color. |
| Q35950243 | Reproductive and genital health and risk of cervical human papillomavirus infection: results from the Ludwig-McGill cohort study |
| Q89633246 | Reviewing the Composition of Vaginal Microbiota: Inclusion of Nutrition and Probiotic Factors in the Maintenance of Eubiosis |
| Q27000738 | Risk of Bacterial Vaginosis Among Women With Herpes Simplex Virus Type 2 Infection: A Systematic Review and Meta-analysis |
| Q33915151 | Risks for acquisition of bacterial vaginosis among women who report sex with women: a cohort study |
| Q94561488 | Saccharomyces cerevisiae-Based Probiotics as Novel Antimicrobial Agents to Prevent and Treat Vaginal Infections |
| Q34405887 | Searching for lower female genital tract soluble and cellular biomarkers: defining levels and predictors in a cohort of healthy Caucasian women |
| Q37635153 | Selected vaginal bacteria and risk of preterm birth: an ecological perspective. |
| Q92239060 | Sexual practices have a significant impact on the vaginal microbiota of women who have sex with women |
| Q36068677 | Soluble Immune Mediators and Vaginal Bacteria Impact Innate Genital Mucosal Antimicrobial Activity in Young Women |
| Q97523935 | Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis |
| Q35920191 | The Human Microbiome during Bacterial Vaginosis. |
| Q38801593 | The Interplay of Host Immunity, Environment and the Risk of Bacterial Vaginosis and Associated Reproductive Health Outcomes |
| Q98771795 | The Penile Microbiota in Uncircumcised and Circumcised Men: Relationships With HIV and Human Papillomavirus Infections and Cervicovaginal Microbiota |
| Q21296754 | The Strong Protective Effect of Circumcision against Cancer of the Penis |
| Q34770567 | The aetiology of bacterial vaginosis. |
| Q35128826 | The barrier to HIV transmission provided by genital tract Lactobacillus colonization |
| Q27692596 | The complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota. |
| Q33547670 | The epidemiology of bacterial vaginosis in relation to sexual behaviour |
| Q92392350 | The genital tract and rectal microbiomes: their role in HIV susceptibility and prevention in women |
| Q51592063 | The impact of prulifloxacin on vaginal lactobacillus microflora: an in vivo study. |
| Q48096223 | The implausible "in vivo" role of hydrogen peroxide as an antimicrobial factor produced by vaginal microbiota |
| Q89767716 | The microbiome and gynaecological cancer development, prevention and therapy |
| Q31148228 | The role of metagenomics in understanding the human microbiome in health and disease |
| Q91303045 | The seminal microbiome in health and disease |
| Q34663224 | The vaginal microbiome: new information about genital tract flora using molecular based techniques |
| Q35078747 | The vaginal microbiota over an 8- to 10-year period in a cohort of HIV-infected and HIV-uninfected women |
| Q97541897 | Understanding the linkages between male circumcision and multiple sexual partnership among married Ghanaian men: Analysis of data from the 2014 Ghana demographic and health survey |
| Q36301992 | Vaginal Microbiome and Its Relationship to Behavior, Sexual Health, and Sexually Transmitted Diseases. |
| Q36012789 | Vaginal Microbiota |
| Q38222809 | Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development |
| Q38055196 | Vaginal infections update |
| Q35040378 | Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota |
| Q36302752 | Women view key sexual behaviours as the trigger for the onset and recurrence of bacterial vaginosis |
| Q35941094 | Women's Views and Experiences of the Triggers for Onset of Bacterial Vaginosis and Exacerbating Factors Associated with Recurrence |
Search more.